Clinical Trial Update: Mechanisms of Low Levels of Apolipoprotein B

View source ↗

Summary

Clinical trial update explores the mechanisms behind low apolipoprotein B levels in cardiovascular contexts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hypobetalipoproteinemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED